T1	p 44 69	in the premature monkey :
T2	p 213 214	(
T3	p 394 403	gestation
T4	p 406 420	Twelve control
T5	p 455 479	of dexamethasone-treated
T6	p 556 566	of control
T7	p 663 681	for males than for
T8	p 690 691	.
T9	p 739 761	excised lungs included
T10	p 792 826	infants from dexamethasone-treated
T11	p 1024 1039	in infants from
T12	i 19 26	hyaline
T13	i 81 106	antenatal dexamethasone .
T14	i 137 171	antenatal glucocorticoid treatment
T15	i 215 234	Macaca nemestrina )
T16	i 271 278	HMD ) .
T17	i 300 325	dexamethasone ( 2 mg/dose
T18	i 438 446	saline .
T19	i 480 484	dams
T20	i 535 538	HMD
T21	i 732 734	of
T22	i 827 831	dams
T23	i 852 855	dry
T24	i 1141 1144	dry
T25	i 1250 1253	dry
T26	i 1341 1360	phosphatidylcholine
T27	i 1367 1368	)
T28	i 1390 1393	dry
T29	i 1512 1525	dexamethasone
T30	i 1571 1576	label
T31	i 1621 1656	. Antenatal dexamethasone treatment
T32	i 1727 1730	HMD
T33	o 206 212	monkey
T34	o 480 484	dams
T35	o 509 518	incidence
T36	o 523 531	severity
T37	o 707 731	volume-pressure behavior
T38	o 762 784	greater distensibility
T39	o 952 974	Accelerated production
T40	o 1004 1023	SAM ) phospholipids
T41	o 1062 1066	dams
T42	o 1097 1120	total lung phospholipid
T43	o 1203 1228	lavage fluid phospholipid
T44	o 1307 1315	alveolar
T45	o 1323 1366	fluid disaturated phosphatidylcholine ( DPC
T46	o 1443 1456	Incorporation
T47	o 1556 1563	portion
T48	o 1593 1605	DPC fraction
T49	o 1688 1710	incidence and severity
T50	o 1811 1862	accelerated maturation of fetal pulmonary functions
T51	o 1922 1940	SAM phospholipid .